BackTowa Pharmaceutical , Ltd. Overview

Towa Pharmaceutical , Ltd. Receivables

Towa Pharmaceutical , Ltd.'s receivables is $61B.

Get informed when a big investor buys or sells

+ Follow
Receivables
$61.28B
↑ 7.64% YoYΔ $4.35B vs prior year quarter

Peer trimmed avg / median

Loading

Towa Pharmaceutical , Ltd. Receivables History

Loading

Towa Pharmaceutical , Ltd. vs. peers: Receivables Comparison

Loading

Towa Pharmaceutical , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Towa Pharmaceutical , Ltd. (4553.T) FAQ

Towa Pharmaceutical , Ltd. (4553.T) currently reports a receivables of $61B as of September 2026. That compares with $57B in the prior-year period — up 7.6% year over year. Use the charts on this page to explore Towa Pharmaceutical , Ltd.'s receivables history and peer comparisons.

Towa Pharmaceutical , Ltd.'s receivables increased from $57B to $61B — a 7.6% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Towa Pharmaceutical , Ltd. reported $61B in receivables as of September 2026. That compares with $57B in the prior-year period — up 7.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $61B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Towa Pharmaceutical , Ltd., and consider following 4553.T for alerts when major investors trade the stock.